$60M Applied Gene and Cell Therapy Center to Focus on Expanded Clinical Trials
Post Date: May 29, 2024 | Publish Date:
Cincinnati Children’s has begun work on an Applied Gene and Cell Therapy Center, which will enable the health system to increase clinical trials of innovative drugs and biological therapeutics for patients with cancer, blood diseases or genetic disorders.
The $60 million project will renovate a 111,000-square-foot building on a 14.6-acre site in Sharonville, OH, about 15 miles north of Cincinnati, to be capable of producing gene and cell therapy products that meet Current Good Manufacturing Practice (cGMP) standards.
Renovation is expected to be completed by summer 2025, with the facility ultimately housing about 100 employees, including biologists and others focused on quality assurance, regulatory compliance, and plant operations.
Read the full announcement
